心脏装置感染的新疗法;移除感染系统后立即重新植入 (POET-PPM)
心血管植入电子设备(CIED)感染的新疗法;移除感染系统后立即重新植入
The goal of this randomized clinical trials is to ascertain the safety and efficacy of immediate reimplantation of cardiac electronic implantable devices in patients with endocarditis and device-infections, compared to standard care, i.e. reimplantation at a later procedure date.
The primary outcome is the occurence of the composite primary endpoint within 6 months of randomization consisting of
- Death
- Symptomatic embolism (systemic arterial embolism or pulmonary embolism)
- Bacteremia og pocket-infection
- Removal of a CIED due to new infection
研究概览
研究类型
注册 (估计的)
阶段
- 第三阶段
联系人和位置
学习联系方式
- 姓名:Henning Bundgaard, MD, DMSc
- 电话号码:35453534
- 邮箱:henning.bundgaard@regionh.dk
研究联系人备份
- 姓名:Mia M Pries-Heje, MD, PhD
- 邮箱:mia.marie.pries-heje.01@regionh.dk
学习地点
-
-
-
Copenhagen、丹麦、2100
- 招聘中
- Rigshospitalet
-
接触:
- Henning Bundgaard, MD
- 电话号码:+45 3545 0512
- 邮箱:Henning.Bundgaard@Regionh.DK
-
Herlev、丹麦、2730
- 招聘中
- Herlev-Gentofte Hospital
-
接触:
- Kasper Iversen, MD, PhD
- 电话号码:004528712753
- 邮箱:Kasper.Karmark.Iversen@regionh.dk
-
-
Copenhagen
-
Frederiksberg、Copenhagen、丹麦、2000
- 招聘中
- Bispebjerg-Frederiksberg Hospital
-
接触:
- Christian Tuxen, MD, PhD
- 电话号码:004521298430
- 邮箱:Christian.Ditlev.Tuxen@regionh.dk
-
-
Nordsjaelland
-
Hillerød、Nordsjaelland、丹麦、3400
- 招聘中
- Hilleroed Hospital
-
接触:
- Malene Wienberg, MD, PhD
- 电话号码:004548293299
- 邮箱:malene.wienberg@regionh.dk
-
-
North Denmark
-
Aalborg、North Denmark、丹麦
- 招聘中
- Aalborg University Hospital
-
接触:
- Gergely Klausz, MD
- 电话号码:004597 66 45 22
- 邮箱:g.klausz@rn.dk
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Culture positive or negative infection of a CIED acording to PI
- Indication for removal of device
- Clinical indication of device removal of existing device (concurrent left-sided IE is not a contraindication).
- Indication for reimplantation of new device
- A minimum of 3 days of sufficient antibiotic treatment (intravenous or oral) has been administered and/or culture negative antibiotic regimen have been adminstered until blood culture is examined.
- stabilization criteria fulfilled i.e. I) negativ blood cultures, II) WBC < 15 mia/L or reduction of min. 25% and III) CRP <50 or min. 25% reduction.
Exclusion Criteria:
- Immunoincompetence (active chemotherapy or prednisone treatment > 20mg/day
- Device-infection within last 6 months (relaps)
- Septic shock
- Stabilization criteria not fulfilled after 10 days of suficient antibiotic treatment
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Immediate reimplantation
Reimplantation in same procedure as removal of device or shortly thereafter. |
Patients will be rendomized 1:1 by computer to recieve either standart care or intervention prior to removal of infected system |
|
有源比较器:Standart care
Reimplantation of device in a second procedure at a later date, after infection has been stabilized/cleared |
Patients will be rendomized 1:1 by computer to recieve either standart care or intervention prior to removal of infected system |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Composite primary outcome
大体时间:within 6 months of randomization
|
Composite endpoint consisting of number of participants with one or more of the following events during follow-up: death, symptomatic embolism (systemic or pulmonary), bacteremia or pocket infection with same bacterial pathogen or removal of device due to new infection. |
within 6 months of randomization
|
合作者和调查者
调查人员
- 首席研究员:Henning Henning、Copenhagen University Hospital, Rigshospitalet
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.